BridgeMD
New treatment option for Cholera
Official title Preventative Intervention for Cholera for 7 Days
ClinicalTrials.gov ID: NCT05166850
What this study is testing
- What it's testing
- The first objective of our study is to develop a theory-driven evidence-based targeted water, sanitation, and hygiene (WASH) intervention for household members of diarrhea patients in South Kivu, Democratic Republic of the Congo (DRC) through formative research and community engagement. The second objective is to conduct a randomized controlled trial of 2,320 household members of 580 severe diarrhea patients to evaluate the effectiveness of the developed targeted WASH intervention in terms of: 1.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Diarrhea patients presenting with three or more loose stools over a 24h period
- Having no running water inside of their home
- Plan to reside in Bukavu for the next 12 months
- Have a child \<5 years in their household
- Have a working mobile phone in the household
You likely can't join if
- No one will be excluded because of age, sex, religion, or sexual preference
- Presenting at the health facility with a fever (COVID-19 prevention)
The study team makes the final eligibility decision.
Where it's taking place
- Bukavu, South Kivu, Democratic Republic of the Congo
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bukavu, South Kivu, Democratic Republic of the Congo. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.